October 1, 2021
CHLAMYDIA SCREENING
Chlamydia is the most commonly reported bacterial sexually transmitted disease in adolescents in the United States. It occurs most often among adolescent and young adult females.1 HEDIS measures the percentage of women 16–24 years of age who were identified as sexually active and who had at least one test for chlamydia during the measurement year. Patients who were dispensed prescription contraception for reasons other than contraception (acne, PCOS) during the measurement year also are included in this metric. Screening is important, as approximately 75% of chlamydia infections in women and 95% of infections in men are asymptomatic. Below is the data for MPP as well as the State of Michigan’s level for Chlamydia screening.
Screening rates for McLaren Physician Partners 2021
|
HEDIS BENCHMARK
|
|
Benchmark
50th Percentile
|
Benchmark 75th Percentile
|
Benchmark
90th Percentile
|
|
58.3%
|
66.1%
|
71.4%
|
(MPP performance is well below the HEDIS 50th percentile as well as the State of Michigan’s rate for all races)
|
WHITE (NON-HISPANIC)
|
HISPANIC
|
BLACK (NON-HISPANIC)
|
|
Den
|
Num
|
Current for Total Membership
|
Den
|
Num
|
Current for Total Membership
|
Den
|
Num
|
Current for Total Membership
|
|
2,136
|
780
|
36.52%
|
1,654
|
552
|
33.37%
|
321
|
170
|
52.96%
|
Data highlights the significant differences in service utilization at the state level by race
(There are clear racial disparities among the screening rate at MPP as well as on the State level)
Screening Guidelines:
- Should be diagnosed by using nucleic acid amplification tests (NAATs) on urogenital sites, including female urine, as well as clinician-collected endocervical, vaginal, and male urethral specimens.
Treatment Guidelines:
- Azithromycin 1g orally as a single oral dose
- Doxycycline 100mg orally twice daily for 7 days**
- Alternatives:
- Tetracycline 500mg orally four times a day for 7 days**
- Erythromycin 500mg orally four times a day for 7 days
- Ofloxacin 200-400mg orally twice a day for 7 days**
- All persons diagnosed with Chlamydia should be rescreened after 3 months
** Pregnant women should not use, and they should be re-tested 4 weeks later for proof of cure
References:
Centers for Disease Control and Prevention (CDC). 2014. “Sexually Transmitted Diseases: Chlamydia—CDC Fact Sheet.” http://www.cdc.gov/std/chlamydia/STDFact-chlamydia-detailed.htm